Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Other Operating Expenses (2018 - 2025)

Avai Bio's Other Operating Expenses history spans 6 years, with the latest figure at $603084.0 for Q1 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A to $603084.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $692040.0, a 2169.58% increase, with the full-year FY2025 number at $769457.0, up 11.53% from a year prior.
  • Other Operating Expenses hit $603084.0 in Q1 2024 for Avai Bio, up from $27967.0 in the prior quarter.
  • Over the last five years, Other Operating Expenses for AVAI hit a ceiling of $603084.0 in Q1 2024 and a floor of $9.0 in Q4 2020.
  • Historically, Other Operating Expenses has averaged $68861.8 across 4 years, with a median of $11293.0 in 2023.
  • Biggest five-year swings in Other Operating Expenses: crashed 99.5% in 2020 and later soared 1184.8% in 2023.
  • Tracing AVAI's Other Operating Expenses over 4 years: stood at $9.0 in 2020, then surged by 119711.11% to $10783.0 in 2022, then surged by 159.36% to $27967.0 in 2023, then soared by 2056.41% to $603084.0 in 2024.
  • Business Quant data shows Other Operating Expenses for AVAI at $603084.0 in Q1 2024, $27967.0 in Q4 2023, and $11293.0 in Q3 2023.